Table 3. Differentially expressed genes in prostate tissue specimens of patients with or without progression to BCR based on expression in tumor only and ratio of expression in tumor vs. normal.
Tumor only | Tumor vs Normal | |||||||||
Probe | p value | q-value | Expected FP | BCR vs Non-BCR | Probe | p value | q-value | Expected FP | BCR vs Non-BCR | |
1 | ERG8 | 3.50E-05 | 0.00287 | 0.003 | ↓ | Pan.ERG | 0.00025 | 0.01594 | 0.016 | ↓ |
2 | ERG1.ERG2.ERG3 | 0.00012 | 0.00505 | 0.010 | ↓ | ERG8 | 0.00036 | 0.01594 | 0.032 | ↓ |
3 | Pan.ERG | 0.00036 | 0.00951 | 0.029 | ↓ | ERG1.ERG2.ERG3 | 0.00124 | 0.03686 | 0.111 | ↓ |
4 | GGT1 | 0.00046 | 0.00951 | 0.038 | ↓ | T2. ERG.exon4.fusion | 0.00342 | 0.06245 | 0.250 | ↓ |
5 | HDAC1 | 0.00158 | 0.02542 | 0.127 | ↓ | TP53 | 0.00349 | 0.06245 | 0.312 | ↓ |
6 | KLK2 | 0.00197 | 0.02542 | 0.153 | ↓ | HDAC1 | 0.00575 | 0.08562 | 0.514 | ↓ |
7 | MYO6 | 0.00214 | 0.02542 | 0.178 | ↓ | NCOA2 | 0.01971 | 0.24723 | 1.731 | ↑ |
8 | PLA2G7 | 0.00283 | 0.02941 | 0.235 | ↓ | VEGFA | 0.02213 | 0.24723 | 1.978 | ↑ |
9 | T2.ERG.exon4.fusion | 0.00319 | 0.02947 | 0.265 | ↓ | PTEN | 0.03389 | 0.30341 | 2.731 | ↓ |
10 | BICD1 | 0.00509 | 0.04225 | 0.422 | ↓ | ACPP | 0.03911 | 0.30341 | 3.034 | ↑ |
11 | CACNA1D | 0.00993 | 0.07502 | 0.825 | ↓ | KLF4 | 0.04010 | 0.30341 | 3.337 | ↑ |
12 | ACPP | 0.02298 | 0.15908 | 1.909 | ↑ | TMPRSS2 | 0.04074 | 0.30341 | 3.641 | ↑ |
13 | FAS | 0.03467 | 0.22155 | 2.880 | ↓ | FAS | 0.04674 | 0.32132 | 4.177 | ↓ |
14 | T2.ERG.exon2.fusion | 0.03828 | 0.22718 | 3.180 | ↓ | HSP27 | 0.06458 | 0.39413 | 5.518 | ↑ |
15 | C.MYC | 0.06511 | 0.34971 | 5.246 | ↓ | T2.ERG.exon2.fusion | 0.06616 | 0.39413 | 5.912 | ↓ |